Please contact our sales representative to learn more information about this reagents.
Background
Varlilumab (INN, development code CDX-1127) is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies. It is an anti-CD27 antibody and helps activate T-cells. This drug was developed by Celldex Therapeutics.